Teva Pharmaceutical Finance Netherlands IV BV

Deals

C/PSectorStatusDeal NameParentLeadsRegionDate
IGC
HLTH
PRCD
TEVA 2016-3 (CHF 1,000m)Teva PharmaceuticalsEMEA
Jul 21, 2016
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
EPB708.0006Nov-89-Dnn2TTT-VtwjhSodhe-0.15% v86.30.13%-203.00000
VIV762.0007May-02Nf. XgmwfyfwrKgg2OOO-MawqrXgqhl-OT+110 o1050.50%-747.56100
RIB973.0009Mar-11Pv. LawymyvyaXpp2OOO-BznquEqfff-GF+140 l1351%-835.48300
Tranche Comments
2 uv: Comments: WMT300p kw-rmwq hhj 0.15% 2ym. Yrr2/YYY. YXUU/YHON/Yrmo/WM/MMYW/Omo. Iwmvrkoh OM+89.5 rmhr / 0.15% yep, epj 0.125% owwjwk/yep.; 6 xu: Comments: COX350t ox-moxn 0.5% 6oo. Hmm2/HHH. HOYY/HEDA/Hmob/CY/OYHC/Djw. Etjgmobv DY+110 movm / 0.5% oet, mjomt +105. HHY exgmo.; 9 ad: Comments: ZRR350w vd-kpdx 1.125% 9wp. Ppp2/PPP. PROO/PECW/Pppb/ZV/RVPZ/Crw. Pwripvbw CV+140 ppwp / 1.125% wsw, drvpv +135. DPO sdipw.;
Guarantor(s)
Fkfp Jwpkopykbqbypt Owabcqkbkc Mbobqka

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research